Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate

Cancer Chemother Pharmacol. 1991;28(2):150-1. doi: 10.1007/BF00689708.

Abstract

Acetazolamide, 500 mg 6 hourly, has been used to alkalinise the urine in patients receiving high dose methotrexate. A urinary pH of greater than 7.5 was achieved in every cycle (13 cycles in 10 patients). In 6 cycles a single supplementary dose of sodium bicarbonate was necessary. Plasma methotrexate levels fell satisfactorily at 24 and 48 h. Acetazolamide is a simple and effective method of achieving urinary alkalinisation with advantages over oral and intravenous bicarbonate.

MeSH terms

  • Acetazolamide / adverse effects
  • Acetazolamide / pharmacology*
  • Humans
  • Hydrogen-Ion Concentration
  • Infusions, Intravenous
  • Kidney / drug effects*
  • Methotrexate / blood
  • Methotrexate / therapeutic use*
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / urine

Substances

  • Acetazolamide
  • Methotrexate